Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Notice of redemption of notes due 2025 guaranteed by Citycon Oyj

Citycon Oyj   Stock exchange release   13 December 2024 at 15:55 hrsNOT TO BE RELEASED, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART IN OR INTO OR TO ANY PERSON LOCATED IN OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES OR THE DISTRICT OF COLUMBIA (TOGETHER THE “UNITED STATES”), AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.   Following the successful tender offer settling today 13 December 2024, Citycon Treasury B.V. has given notice to the trustee

Nightingale Health Plc: Subscription of Series B shares with option rights

Nightingale Health PlcCompany release13 December 2024 at 3:50 p.m. (EET) Based on Nightingale Health Plc’s option program 2023-ML, 3,600 new Series B shares have been subscribed. As a result of the share subscription approved by Nightingale Health’s Board of Directors on 21 November 2024, the number of Series B shares in the company will increase from 40,293,221 to 40,296,821 shares. The subscription price of the subscriptions made with the option rights, EUR 9,000, will be entered in the company’s reserve for invested unrestricted equity.   The shares subscribed with option

Founder and board member subscribes for shares in the ongoing rights issue

Peter Egelberg, founder and Board member of Phase Holographic Imaging PHI AB (“PHI” or the “Company”) has notified the Company that he, together with closely related parties, follows Altium SA’s lead by subscribing for shares in the Company’s ongoing fully secured rights issue. The subscription amounts to approximately 300 TSEK.Peter Egelberg, founding Board Member of PHI, comments “The lack of robust automation has long limited the use of microscopy in manufacturing environments. Since resigning as CEO, I have gone back to my roots in software development, AI, physics and mathematics to

Saab receives order from Sweden for Sea Giraffe 1X naval radar

Saab has received an order from the Swedish Defence Materiel Administration (FMV) for the Sea Giraffe 1X radar system to the Swedish navy. The order value is approximately SEK 340 million with deliveries 2024-2026.The order includes Saab’s Sea Giraffe 1X naval radar system in different configurations for training as well as installation on surface ships. “We are happy to continue to provide the Swedish Navy with modern radar systems. Sea Giraffe 1X will contribute in protecting costal and littoral areas and strengthen the naval units with advanced capabilities to detect, track and

Boomerang Partners Nominated for Affiliate Program of the Year at Global Gaming Awards EMEA 2025

Boomerang Partners  has been named a finalist in the prestigious Affiliate Program of the Year category at the Global Gaming Awards EMEA 2025. This recognition highlights the company’s great successful effort in building a strong relationship with affiliates.This year, Boomerang Partners has solidified its position as a leading global company through proactive initiatives, close collaboration with the affiliate community, strategic partnerships to enhance brand awareness, and innovation in business

Form 8.3 - Britvic Plc

FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   +------------------------------------------------+----------------------------+|(a) Full name of discloser: |Magnetar Capital Partners LP|+------------------------------------------------+----------------------------+|(b) Owner or controller of interests and short |  ||positions disclosed, if different from 1(a):

Wärtsilä to divest its Automation, Navigation and Control System business to Solix

Wärtsilä Corporation, Press release, 13 December 2024 at 15.15 EETTechnology group Wärtsilä has agreed to divest its Automation, Navigation and Control System (ANCS) business to the Swedish investment company Solix Group AB.   ANCS is a global leader in innovative hardware and software technologies for marine navigation and automation, with solutions including integrated navigation and automation systems, advanced sensors enhancing safety and situational awareness, and dynamic positioning systems enabling precise vessel station keeping. Wärtsilä acquired ANCS in 2015 as part of Marine

Norconsult acquires infrastructure consulting company Sigma Civil in Sweden

Sandvika, 13 December 2024 (OSE: NORCO): Norconsult has acquired the Swedish infrastructure consulting company Sigma Civil AB. The acquisition aligns with Norconsult’s strategy of Nordic growth and local presence, and is set to broaden Norconsult’s expertise, while expanding its geographical footprint in the Swedish market. Sigma Civil has 125 employees, with offices in Malmö (head office), Göteborg, Umeå and Karlstad.  The Company specialises in water and sewage, landscape planning, traffic, roads and streets, project management, environment and construction, serving predominantly

Patria’s Executive Vice President, Global and member of Patria Group Management Jukka Holkeri to retire

Jukka Holkeri, Executive Vice President, Global and member of Patria Group Management, has informed that he will be retiring as of 1 of June, 2025.Jukka Holkeri has been leading Patria’s Global Division since 2022. He joined Patria in 1988 and, over 36 years, held many significant executive positions. During these years, Jukka Holkeri has held numerous significant executive positions within the Group, including executive positions in leading business units, responsibility for Patria's strategy process and development, and executive positions in marketing and sales.  "I warmly thank

Chenille steps into the spotlight in Getinge’s 2024 company video

Chenille Perry, a Complaints Analyst at Getinge, recently stepped out of her comfort zone to participate in Getinge’s 2024 company video, showcasing the medtech company’s dedication to life-saving technology. Getinge’s new company video features an all-employee cast. For Chenille Perry, the opportunity to participate in it was both exciting and challenging. “It was a chance to represent Getinge in a meaningful way,” she explains. “I’ve always focused on my work behind the scenes, but I couldn’t pass up this chance to do something new.” The theme of the video – darkness and

The Board of Directors of Nurminen Logistics Oyj has decided on a directed share issue to complete the acquisition of Essinge Rail Ab

Nurminen Logistics Plc            Stock Exchange Release  December 13, 2024, at 01.00 p.m. Nurminen Logistics Oyj ("the Company") announced on 11 November 2024 its decision to acquire the entire share capital of Essinge Rail Ab. The Company has received the necessary regulatory approvals to complete the acquisition, and all other closing conditions have been fulfilled. Consequently, the acquisition was completed today. Based on the authorization granted by the Annual General Meeting on 17 April 2024, the Board of Directors of the Company has resolved on a directed issue of 2,339,756

Viking Line Abp: Managers' Transactions

Viking Line Abp MANAGERS' TRANSACTIONS 13.12.2024, 1.00 PMManagers' transactionsViking Line Abp has today received the following notification pursuant to Article 19 of the EU Market Abuse Regulation from a person closely associated with a person discharging managerial responsibilities in Viking Line Abp. Viking Line Abp - Managers' Transactions____________________________________________Person subject to the notification requirementName: Maelir ABPosition: Closely associated person(X) Legal person  (1):Person Discharging Managerial Responsibilities In IssuerName: Jakob

Everfuel and Karlstads Energi gets funding notification for potential project in Sweden

Herning, Denmark, 13 December 2024 – Everfuel A/S' is pleased to announce that its subsidiary Everfuel Production Karlstad AB have been awarded a grant by the Swedish Environmental Protection Agency under the Climate Leap (Klimatklivet) investment program following a funding application made in 2022, for the potential 20 MW electrolyser project. The project is a joint initiative with the local utility company, Karlstads Energi.    The project grant is subject to the parties moving forward with the project and fulfilling the grant conditions. If finally awarded, the grant would be in an

#24-122 Information regarding the last day of trading in paid subscribed units and the first day of trading in warrants issued by Attana AB

The unit issue in Attana AB (“The Company”) is now registered with the Swedish Companies Registration Office and the last day of trading in paid subscribed units has been set for December 17, 2024.   The first day of trading for the Company’s warrants series 2 (TO2) and warrants series 3 (TO3) has been set for December 23, 2024.   Information regarding the affected instruments:   Listing name: Attana BTU Exchange symbol: ATANA BTUISIN-code: SE0023114459 CFI-code: MCMUXR FISN-code: ATTANA/UT 4 AK + 4 TO Last day of trading: 2024-12-17 Instrument-ID: G141

Form 8 (OPD) - De La Rue Plc

FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   +----------------------------------------------------------+------------------+|(a) Full name of discloser: |Ninety One UK Ltd |+----------------------------------------------------------+------------------+|(b) Owner or controller of interests and short positions |  ||disclosed, if different from 1(a):

Cereno Scientific to present and engage in partnering and investor meetings at Biotech Showcase 2025 during J.P. Morgan Healthcare Week in San Francisco

Cereno Scientific (Nasdaq First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announces that the company is attending the Biotech Showcase 2025 conference during J.P. Morgan Healthcare Week. CEO Sten R. Sörensen will hold a presentation at the conference, which takes place Januari 13-15 at the Hilton San Francisco Union Square, San Francisco.Sten R. Sörensen, CEO, will together with Rahul Agrawal, Chief Medical Officer and Head of R&D and Jeppe Øvlesen, Board Member, participate at the

Form 8.3 - Direct Line Insurance Group Plc

FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   +----------------------------------------------+-------------------------------+|(a) Full name of discloser: |Ninety One UK Ltd |+----------------------------------------------+-------------------------------+|(b) Owner or controller of interests and short|  ||positions disclosed, if different from

Cinis sends additional shipload of potassium sulfate and tests logistics solution

Cinis Fertilizer has sent another shipload of premium quality water soluble potassium sulfate to Van Iperen International. The cargo amounts to about 3,200 tons and was sent south with the same vessel that delivered input materials, an important step in the optimization of the company's logistics flow.The production ramp-up at Cinis Fertilizer's facility in Köpmanholmen continues and now another shipload of water-soluble potassium sulfate has been left port. The entire cargo, about 3,200 tons, exceeds the highest quality requirements for water-soluble potassium sulfate. The delivery was

Horses feel strongly – and scientists know what they need to be happy

[Patting and scratching - The Mind of a Horse.jpg] Joy. Fear. Affection. The science of animal emotions has confirmed what many animal owners have long known: animals do have intense emotions. However, what they actually feel is not always what owners are used to thinking. “Advances in the science of animal emotions have had a transformative effect on our worldview,” says Dr Helena Telkanranta, the main author of the acclaimed nonfiction graphic novel The Mind of a Horse. Science Meets Comics. “Scientists now know that all mammals, birds, and even fish do experience basic emotions,

Educating people-centred dentists for rural Australia

Charles Sturt University recently upgraded the dental units at one of their clinics, significantly enhancing clinical training for students and dental care services for the local community. The decision to choose Planmeca was heavily influenced by their experiences with the previous units and the exceptional service received. Initial feedback on the new units has been overwhelmingly positive – from staff, students, and patients.[Charles_Sturt_University_04.jpg] Beyond the Blue Mountains, approximately a three-and-a-half-hour drive west of Sydney, lies the charming rural town of Orange.

Bulletin from the extraordinary general meeting in SciBase Holding AB (publ)

Today, an extraordinary general meeting has been held in SciBase Holding AB (publ) ("SciBase" or the "Company"). The general meeting resolved in accordance with the proposals presented in the notice to convene the meeting (which is available on the Company's website (www.scibase.com)):Amendment of the articles of associationThe general meeting resolved, in accordance with the board of directors' proposal, to amend §§ 4-5 of the articles of association, entailing that the articles of association shall be amended so that the Company's share capital shall be not less than SEK 16,440,000 and

Diamyd Medical Aligns with FDA on Key Elements for an Accelerated Approval Process

Diamyd Medical today announced a positive in-person Type C meeting with the U.S. Food and Drug Administration (FDA), where alignment was achieved on key components of the planned early readout and an accelerated approval pathway for the antigen-specific immunotherapy, Diamyd[®] (rhGAD65/alum). Additional details of the FDA interaction will be disclosed upon receipt of the final meeting minutes, expected in January 2025.“We are very pleased with the positive and constructive dialogue and the alignment achieved with the FDA on key elements of the accelerated readout procedure,” says Ulf

Announcement in connection with the tender and exchange offers

THIS ANNOUNCEMENT RELATES TO THE DISCLOSURE OF INFORMATION THAT QUALIFIED OR MAY HAVE QUALIFIED AS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE MARKET ABUSE REGULATION (EU) 596/2014. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES OF AMERICA, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS), ANY STATE OF THE UNITED STATES OF AMERICA AND THE DISTRICT OF COLUMBIA (the "United States") OR TO ANY U.S. PERSON (AS

There are no items matching the current filter
There are no more items matching the current filter
Back to top